BR112017000359A2 - combinação de pregabalina e meloxicam para o tratamento de dor neuropática - Google Patents

combinação de pregabalina e meloxicam para o tratamento de dor neuropática

Info

Publication number
BR112017000359A2
BR112017000359A2 BR112017000359-7A BR112017000359A BR112017000359A2 BR 112017000359 A2 BR112017000359 A2 BR 112017000359A2 BR 112017000359 A BR112017000359 A BR 112017000359A BR 112017000359 A2 BR112017000359 A2 BR 112017000359A2
Authority
BR
Brazil
Prior art keywords
pregabalin
treatment
neuropathic pain
meloxicam
combination
Prior art date
Application number
BR112017000359-7A
Other languages
English (en)
Inventor
Elena Garcia Armenta Maria
Guillermo Álvarez Ochoa Victor
Original Assignee
Pptm Int S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53938368&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017000359(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pptm Int S A R L filed Critical Pptm Int S A R L
Publication of BR112017000359A2 publication Critical patent/BR112017000359A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112017000359-7A 2014-07-07 2015-07-07 combinação de pregabalina e meloxicam para o tratamento de dor neuropática BR112017000359A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MXMX/A/2014/008336 2014-07-07
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
PCT/IB2015/055127 WO2016005897A1 (en) 2014-07-07 2015-07-07 Combination of pregabalin and meloxicam for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
BR112017000359A2 true BR112017000359A2 (pt) 2018-06-26

Family

ID=53938368

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000359-7A BR112017000359A2 (pt) 2014-07-07 2015-07-07 combinação de pregabalina e meloxicam para o tratamento de dor neuropática

Country Status (5)

Country Link
BR (1) BR112017000359A2 (pt)
CO (1) CO2017001076A2 (pt)
MX (1) MX2014008336A (pt)
PE (1) PE20171140A1 (pt)
WO (1) WO2016005897A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590094B2 (en) 2017-09-28 2023-02-28 Nevakar Injectables Inc. Fixed dose combination formulations for treating pain
MX2019008467A (es) * 2019-07-16 2019-11-07 Federico Amezcua Amezcua Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico.
CN112353767A (zh) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129907A (en) 1999-08-04 2000-10-10 Colgate Palmolive Company Stable hydrogenated lupulone antibacterial oral compositions
WO2003066040A1 (fr) 2002-02-05 2003-08-14 Ajinomoto Co.,Inc. Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n
DE10331305A1 (de) 2003-07-10 2005-02-17 Siemens Ag Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
WO2006123247A2 (en) 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CA2701838A1 (en) 2007-10-09 2009-04-16 Merck Patent Gmbh Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
MX2010005680A (es) 2007-11-23 2010-12-21 Protect Pharmaceutical Corp Composiciones de tapentadol.
MX336979B (es) 2011-12-16 2016-02-09 Senosiain S A De C V Lab Combinacion farmaceutica antineuritica y composiciones.

Also Published As

Publication number Publication date
PE20171140A1 (es) 2017-08-09
MX2014008336A (es) 2016-01-07
WO2016005897A1 (en) 2016-01-14
CO2017001076A2 (es) 2017-05-31

Similar Documents

Publication Publication Date Title
ES2769863T8 (es) 7-hidroxi-cannabidivarín (7-OH-CBDV) para usar en el tratamiento de la epilepsia
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
BR112016021682A2 (pt) cenicriviroc para o tratamento da fibrose
BR112016027041A2 (pt) Combinações farmacêuticas para tratamento do câncer
BR112016022976A2 (pt) Métodos para o tratamento de hcv
BR112017024253A2 (pt) métodos de tratamento de inflamação ou dor neuropática.
ZA201802498B (en) Ozonolysis for activation of compounds and degradation of ozone
IL262825A (en) Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
HK1249865B (zh) 疼痛的治療
HK1244711A1 (zh) Hmgb1介導的炎症的治療
BR112016026369A2 (pt) combinações de formoterol e budesonida para tratamento de copd.
DK3326635T3 (da) Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod
BR112017000359A2 (pt) combinação de pregabalina e meloxicam para o tratamento de dor neuropática
GB2548491B (en) Treatment of fluids
IL250594A0 (en) The composition for the treatment of nerve diseases and/or neuropathic pain
IL266243A (en) Use of senicapoc for the treatment of neuropathic pain
HK1252359A1 (zh) 用於治療疼痛的曲唑酮和加巴噴丁的組合
BR112016029238A2 (pt) método e aparelhos para fornecer uma solução para o tratamento de sangue.
GB201411616D0 (en) Diagnosis and treatment of neurodegenerative disorders
GB201603755D0 (en) Treatment of hypothyroidism
GB201603752D0 (en) Treatment of hypothyroidism
ES1113580Y (es) Dispositivo dental para el tratamiento de la onicofagia
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
ES1165233Y (es) Dispositivo para el tratamiento de olores desagradables

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE. PAGAR RESTAURACAO.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2703 DE 25/10/2022 POR TER SIDO INDEVIDA, UMA VEZ QUE O RECOLHIMENTO DA 7A ANUIDADE FOI EFETUADO EM 09/08/2021, ATRAVES DA GRU 29409161938157370.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]